2016
Review: Novel Insights Into Tumor Necrosis Factor Receptor, Death Receptor 3, and Progranulin Pathways in Arthritis and Bone Remodeling
Williams A, Wang E, Thurner L, Liu C. Review: Novel Insights Into Tumor Necrosis Factor Receptor, Death Receptor 3, and Progranulin Pathways in Arthritis and Bone Remodeling. Arthritis & Rheumatology 2016, 68: 2845-2856. PMID: 27428882, PMCID: PMC5599977, DOI: 10.1002/art.39816.Peer-Reviewed Original Research
2015
Does progranulin account for the opposite effects of etanercept and infliximab/adalimumab in osteoarthritis?
Wei J, Buza J, Liu C. Does progranulin account for the opposite effects of etanercept and infliximab/adalimumab in osteoarthritis? Journal Of Orthopaedic Research® 2015, 34: 12-14. PMID: 26519939, PMCID: PMC4710548, DOI: 10.1002/jor.23091.Peer-Reviewed Original Research